General Information
Product name
Heparin Sodium Inj. USP
Manufacturer Name
Hospital Products Division
Emergency telephone
1-847-937-7970, 1-800-424-9300
Icons in SDS
Company Information
company name
Hospital Products Division
Section 2
Principle Routes of Exposure
Skin: Unlikely Inhalation: Unlikely Ingestion: Unlikely 3. HAZARDS INFORMATION, continued ----------------------- INGESTION RATING: None SKIN ABSORPTION RATING: N/D INHALATION RATING: N/D CORROSIVENESS RATING: N/D SKIN CONTACT RATING: N/D SKIN SENSITIZATION RATING: N/D EYE CONTACT RATING: N/D TARGET ORGANS: Hematopoietic system. CARCINOGENICITY RATING NTP N/L IARC N/L OSHA N/L ACGIH: N/L None SIGNS AND SYMPTOMS: N/D. In clinical use, heparin can produce hemorrhage, prolongation of coagulation test times, increased susceptability to bruising, bleeding, decrease in thrombocytes, and elevation in liver function parameters. Allergic reactions have occurred. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: N/D. Hypersensitivity to heparin. Thrombocytopenia, bleeding, prolonged coagulation tests, use of oral anticoagulants, use of platelet inhibitors and liver ailments.
